2022-502216-36-00已完成1 期
Study of exposure to substances prohibited by the World Anti-Doping Agency in healthy volunteers. Proof of concept.
Municipal Institute Of Medical Investigation, Hospital Del Mar1 个研究点 分布在 1 个国家目标入组 28 人开始时间: 2023年2月13日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 28
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 性别
- Male
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Ana Maria Aldea Perona
Scientific
Hospital Del Mar
研究点 (1)
Loading locations...
相似试验
招募中
1 期
Study of exposure to substances prohibited by the World Anti-Doping Agency in healthy volunteers (ESPAMA_3). Proof of concept2024-519780-18-00Consorci Mar Parc De Salut De Barcelona21
招募中
1 期
A study to evaluate the safety and tolerability of single ascending doses of AGMB-101 in healthy participants (Part A) and patients with liver cirrhosis (Part B).2024-515074-26-00AgomAb Therapeutics64
已完成
1 期
A Study to Evaluate the Safety and Tolerability of JNJ-77730614 When Given as Single and Multiple Doses to Healthy Participants to Assess How Long JNJ 77730614 Stays in the Body (Pharmacokinetics) and How the Body Responds to it (Pharmacodynamics)2023-505684-36-00Janssen - Cilag International92
招募中
1 期
A study to investigate the safety, the amount that reaches the bloodstream and the effects on the body of JNJ-64619178 in people with advanced cancers2024-515254-24-00Janssen Cilag International74
招募中
1 期
Study to Investigate the Safety and Tolerability of Odronextamab in Patients With CD20+ B-Cell Malignancies2024-514938-20-00Regeneron Pharmaceuticals Inc.65